Abstract
The objective of the study is to summarise the association between COVID-19 and smoking published in peer-reviewed journals, preprint in MedRxiv /Qeios, news, and report. The literature search was conducted between 1st to 20th August 2020 using three databases (PubMed, Google Scholar, and Google) with the keywords “Tobacco smoking and COVID-19” as search terms. A French study claimed that smoking is a protective agent for COVID-19 infection. A meta-analysis revealed that tobacco smoking is significantly associated with COVID-19 infection. Despite the controversy surrounding the connection between smoking and COVID-19, people should not smoke or use any tobacco products because smoking is associated with increased rates of severe COVID-19.
References
WHO. Smoking and COVID-19 [Internet] . Geneva;WHO;2020 [cited 2020 Sep 8]. Available from: https://www.who.int/news-room/commentaries/detail/smoking-and-covid-19.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb;395(10223):497-506. [PubMed | FullText | DOI]
Tadic M, Cuspidi C, Sala C. COVID-19 and diabetes: Is there enough evidence?. J Clin Hypertens. 2020 May;22(6):943-48. [PubMed | FullText | DOI]
Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, et al. Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-8. [PubMed | FullText | DOI]
Huang I, Lim MA, Pranata R. Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia – A systematic review, meta-analysis, and meta-regression: Diabetes and COVID-19. Diabetes Metab Syndr. 2020;14(4):395-403. [PubMed | FullText | DOI]
Pranata R, Lim MA, Huang I, Raharjo SB, Lukito AA. Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis, and metaregression. J Renin Angiotensin Aldosterone Syst. 2020: 21(2):1-11. [PubMed | FullText | DOI]
Engin AB, Engin ED, Engin A. Two important controversial risk factors in SARS-CoV-2 infection: Obesity and smoking. Environ Toxicol and Pharmacol.2020 Aug;78:103411. [PubMed | FullText | DOI]
MedRxiv. The preprint server for health sciences. MedRxiv;2020[cited 2020 Aug 22]. Available from: https://www.medrxiv.org.
Qeios. Posting Policy. Qeios; 2020 [cited 2020 Aug 22] . Available from: https://www.qeios.com/ posting-policy.
Gilmore A. Review of: “Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19.” Qeios 2020. [FullText | DOI]
Israel A, Feldhamer I, Lahad A, Levin-Zamir D, Lavie G. Smoking and the risk of COVID-19 in a large observational population study. medRxiv. 2020 Jun; 20118877. [FullText]
Patanavanich R, Glantz SA. Smoking is Associated with COVID-19 Progression: A meta-analysis. Nicotine Tob Res. 2020;22(9):1653-56. [PubMed | FullText | DOI
Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R. Current smoking, former smoking, and adverse outcome among hospitalised COVID-19 patients: A systematic review and meta-analysis. TherAdv Chronic Dis 2020;11:2040622320935765. [PubMed | FullText | DOI]
Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization, and mortality from COVID-19: A living evidence review.Qeios.2020 Aug. [FullText | DOI]
Norden MJ, Avery DH, Norden JG, Haynor DR. National Smoking Rates Correlate Inversely with COVID-19 Mortality. medRxiv. 2020 Jan. [FullText]
Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associated with disease outcomes in hospitalised patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020 Feb.2020;133(9);1032-8. [PubMed | FullText | DOI]
Alqahtani JS, Oyelade T, Aldhahir AM, Alghamdi SM, Almehmadi M, Alqahtani AS, et al. Prevalence, severity, and mortality associated with COPD and smoking in patients with COVID-19: A rapid systematic review and meta-analysis. PLoS One. 2020; 15(5):e0233147. [PubMed | DOI]
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;15(5): e0233147. [PubMed | DOI]
Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy.2020; 75(7):1730-41. [PubMed | FullText | DOI]
Giannouchos T, Sussman R, Mier JM, Poulas K, Farsalinos K. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19 cases. Eur Respir J.2020;2002144. [FullText | DOI]
Yach D, Pratt A, Glynn TJ, Reddy KS. Research to stop tobacco deaths. Global Health. 2014;10:39.[PubMed | FullText | DOI]
Cash R, Patel V. Has COVID-19 subverted global health?. Lancet. 2020;395(10238):1687-8. [PubMed | FullText | DOI]
John Hopkins Corona Resource Center. Mortality Analysis[Internet] .United States of America: John Hopkins Corona Resource Center;2020.[cited 2020 Aug 19]. Available from: https://coronavirus.jhu. edu/data/mortality.
World Economic Forum.COVID-19: Collaboration is the engine of global science – especially for developing countries[Internet]. World Economic Forum;2020[cited 2020 Aug 20]. Available from: https://www.weforum.org/agenda/2020/05/globalscience-collaboration-open-source-covid-19.
Zhao Q, Meng M, Kumar R, Wu Y, Huang J, Lian N, Deng Y, Lin S. The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis. J Med Virol. 2020 Oct;92(10):1915-21. [PubMed | FullText | DOI]
Zheng Z, Peng F, Xu B, Zhao J, Liu H, Peng J et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. J Infect.2020;81(2): e16-25. [PubMed | FullText | DOI]
WHO. Global youth tobacco survey(GYTS)[Internet]. Geneva:WHO;2020. [Cited 2020 Aug 21] . Available from:https://www.who.int/tobacco/surveillance/ gyts/en/.
CDC. Global adult tobacco survey(GATS) [Internet] .Atlanta: CDC;2020. [Cited 2020 Aug 21] . Available from:https://nccd.cdc. g o v / G T S S D a t a S u r v e y R e s o u r c e s / A n c i l l a r y / Documentation.aspx?SUID=4&DOCT=1.
Sauro J. Advantages of standardised usability questionnaires [Internet]. Denver: Measuring U;2020. [cited on 2020 Aug 21] . Available from:https:// measuringu.com/standardised-usability/.
Hefler M. Smokeless tobacco use and the COVID-19 pandemic. Blog|Tobacco Control[Internet] . 2020 March 30 [cited 2020 Aug 20] .Available from:https:// blogs.bmj.com/tc/2020/03/30/smokeless-tobaccouse-and-the-covid-19-pandemic/.
The Washington Post. Virus ban gives tobacco illegal drug status in South Africa [Internet] . The Washington Post; July 2020[cited 2020 Aug 20] . Available from:https://www.washingtonpost.com/ world/africa/ban-gives-tobacco-illegal-drug-statusin-south-africa/2020/07/02/ad3c2256-bc31-11ea- 97c1-6cf116ffe26c_story.html.
The Economic Times. 28 states, UTs ban smokeless tobacco products, spitting due to Coronavirus[Internet] . India: The Economic Times; May 2020 [cited 2020 Aug 20] . Available from:https://economictimes.indiatimes.com/news/ politics-and-nation/28-states-uts-ban-smokelesstobacco-products-spitting-due-to-coronavirus/ articleshow/75657382.cms.